Lymphoma-associated retinopathy

Ophthalmology

Volumn 109, Issue 11, 2002, Pages 2149-2153

  To, King W ^a   Thirkill, Charles E ^b   Jakobiec, Frederick A ^a   Lessell, Simmons ^a   Berson, Eliot L ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIBODY; BLEOMYCIN SULFATE; CORTICOSTEROID; DACARBAZINE; DOXORUBICIN; GLUTAMATE DECARBOXYLASE ANTIBODY; IODINE 125; PREDNISONE; PROTEIN ANTIBODY; VINBLASTINE SULFATE;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRORETINOGRAPHY; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOBLOTTING; LYMPHOMA; PRIORITY JOURNAL; RETINA DEGENERATION; RETINOPATHY; VISUAL ACUITY; VISUAL FIELD;

ADULT; ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; BLOTTING, WESTERN; ELECTRORETINOGRAPHY; EYE PROTEINS; FEMALE; HODGKIN DISEASE; HUMANS; NIGHT BLINDNESS; PARANEOPLASTIC SYNDROMES; PREDNISONE; RETINA; RETINAL DEGENERATION; VISUAL ACUITY; VISUAL FIELDS;

EID: 0036841647     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01261-7     Document Type: Article

References (41)

1. Anderson NE, Rosenblum MK, Graus F, et al. Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurology 1988;38:1391-8.
2. Lang B, Newsom-Davis J, Wray D, et al. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981;2:224-6.
3. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 1976;81:606-13.
4. Grunwald GB, Klein R, Simmonds MA, Kornguth SE. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma. Lancet 1985;1:658-61.
5. Keltner JL, Thirkill CE, Tyler NK, Roth AM, Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 1992;110:48-53.
6. Kornguth SE, Klein R, Appen R, Choate J. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 1982;50:1289-93.
7. Polans AS, Burton MD, Haley TL, et al. Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1993;34:81-90.
8. Polans AS, Witkowska D, Haley TL, et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 1995;92:9176-80.
9. Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol 1987;105:372-5.
10. Thirkill CE, Keltner JL, Tyler NK, Roth AM. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol 1993;111:931-7.
11. Berson EL, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 1988;106:307-11.
12. Kim RY, Retsas S, Fitzke FW, et al. Cutaneous melanoma-associated retinopathy. Ophthalmology 1994;101:1837-43.
13. Remulla JF, Pineda R, Gaudio AR, Milam AH. Cutaneous melanoma-associated retinopathy with retinal periphlebitis [letter]. Arch Ophthalmol 1995;113:854-85.
14. Andréasson S, Ponjavic V, Ehinger B. Full-field electroretinogram in a patient with cutaneous melanoma-associated retinopathy. Acta Ophthalmol (Copenh) 1993;71:487-90.
15. Rush JA. Paraneoplastic retinopathy in malignant melanoma [letter]. Am J Ophthalmol 1993;115:390-1.
16. Singh AD, Milam AH, Shields CL, et al. Melanoma-associated retinopathy. Am J Ophthalmol 1995;119:369-70.
17. Milam AH, Saari JC, Jacobson SG, et al. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy, Invest Ophthalmol Vis Sci 1993;34:91-100.
18. Alexander KR, Fishman GA, Peachey NS, et al. 'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 1992;33:477-83.
19. Weinstein JM, Kelman SE, Bresnick GH, Kornguth SE. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology 1994;101:1236-43.
20. Mullaney J, Mooney D, O'Connor M, McDonald GS. Bilateral ovarian carcinoma with bilateral uveal melanoma. Br J Ophthalmol 1984;68:261-7.
21. Ehabbakh GM, Hoogerland DL, Kay MC. Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol 1995;58:120-34.
22. Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration: Possible autoimmune disorder. Arch Ophthalmol 1983;101:564-9.
23. Crofts JW, Bachynski BN, Odel JG. Visual paraneoplastic syndrome associated with undifferentiated endometrial carcinoma. Can J Ophthalmol 1988;23:128-32.
24. Campo E, Brunier MN, Merino MJ. Small cell carcinoma of the endometrium with associated ocular paraneoplastic syndrome. Cancer 1992;69:2283-8.
25. Ohkawa T, Kawashima H, Makino S, et al. Cancer-associated retinopathy in a patient with endometrial cancer. Am J Ophthalmol 1996;122:740-2.
26. Adamus G, Amundson D, MacKay C, Gouras P. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy [letter]. Arch Ophthalmol 1998;116:251-3.
27. Gershoni JM, Palade GE. Protein blotting: Principles and applications. Anal Biochem 1983;131:1-15.
28. Solimena M, Folli F, Aparisi R, et al. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990;322:1555-60.
29. Schmidli RS, Harrison LC. Glutamic acid decarboxylase autoantibodies in diabetes mellitus. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. New York: Elsevier Science, 1996;299-307.
30. Kaufman DL. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. New York: Elsevier Science, 1996;308-13.
31. Berson EL, Sandberg MA, Rosner B, et al. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol 1985;99:240-51.
32. Polans AS, Buczylko J, Crabb J, Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 1991;112:981-9.
33. Thirkill CE, Tait RC, Tyler NK, et al. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci 1992;33:2768-72.
34. Keltner JL, Thirkill CE. Cancer-associated retinopathy vs recoverin-associated retinopathy [editorial] [published erratum appears in Am J Ophthalmol 1998;126:866]. Am J Ophthalmol 1998;126:296-302.
35. Matsubara S, Yamaji Y, Sato M, et al. Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines. Br J Cancer 1996;74:1419-22.
36. Yamaji Y, Matsubara S, Yamadori I, et al. Characterization of a small-cell-lung-carcinoma cell line from a patient with cancer-associated retinopathy. Int J Cancer 1996;65:671-6.
37. Heckenlively JR, Fawzi AA, Oversier J, et al. Autoimmune retinopathy: Patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol 2000;118:1525-33.
38. Suzuki T, Obara Y, Sato Y, et al. Cancer-associated retinopathy with presumed vasculitis. Am J Ophthalmol 1996;122:125-7.
39. Murphy MA, Thirkill CE, Hart WM Jr. Paraneoplastic retinopathy: A novel autoantibody reaction associated with small-cell lung carcinoma. J Neuroophthalmol 1997;17:77-83.
40. Takahashi K, Suzuki J, Ohguro H, et al. [A case of paraneoplastic retinopathy with serum antibody against retinal soluble 70 kDA protein]. Nippon Ganka Gakkai Zasshi 1997;101:92-6.
41. Sekiguchi I, Suzuki M, Sato 1, et al. Rare case of small-cell carcinoma arising from the endometrium with paraneoplastic retinopathy. Gynecol Oncol 1998;71:454-7.